window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-108383172-1');
News2018-04-19T09:59:16+02:00

All the news from Novigenix

Follow all the news from Novigenix

Novigenix Strengthens Board with Appointment of Francois Martelet, M.D. Non-Executive Director

LAUSANNE, SWITZERLAND - 07:00 CET, June 18, 2019 - Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes products for early cancer detection and precision medicine today announced the appointment of Francois Martelet, M.D. to its Board of Directors as a non-executive director. Dr. Martelet has over 25 years’ experience at both corporate and operational level in pharmaceutical and biotech

Novigenix Developing NGS Version of Early Colorectal Cancer Detection Test

NEW YORK (GenomeWeb) – With a new CEO at its helm, Swiss molecular diagnostic firm Novigenix is developing a new version of Colox, its mRNA-based assay for early colorectal cancer detection that applies next-generation sequencing instead of RT-PCR.   The firm began a study earlier this year to validate the assay, which measures cancer-specific transcriptomic signatures in circulating immune cells,

Novigenix Appoints Dr. Jan Groen as CEO to Lead Expansion to Multi-Product Cancer Diagnostic Platform Company

ImmunoTranscriptomic platform combines identification of immune cell mRNA signatures with AI for early cancer detection   LAUSANNE, SWITZERLAND - 07:00 CET, May 13, 2019 - Novigenix SA, a leading ImmunoTranscriptomics company that develops and commercializes products for early cancer detection and precision medicine today announced the appointment of Dr. Jan Groen to the position of Chief Executive Officer and member of

Mars Bleu, a campaign to raise awareness about colorectal cancer screening

Mars Bleu, a campaign to raise awareness about colorectal cancer screening   You may have heard about Pink October, a month dedicated to breast cancer awareness and screening. If you didn’t know it yet, there is also the national colorectal cancer awareness month; it’s March and it’s called Mars Bleu (Blue March). Colorectal cancer is the second most deadly cancer

Interview Jan Groen: Colorectal Cancer Blood Test Driven by Immuno-transcriptomics

Source: TNMichele Wilson PhDScience Writer Immuno-transcriptomics is a field of study focused on analyzing gene expression modifications (mRNA signatures) induced by the immune response to various triggers, such as the onset of cancer. Through deep neural network and machine learning, Novigenix are generating mathematical models based on these mRNA signature analyses to predict the onset and progression of disease – in particular,

Geneva pharmacies engage in the fight against colorectal cancer

Geneva pharmacies engage in the fight against colorectal cancer   The campaign “Mars Bleu” (Blue March) is an opportunity to develop a new network and to make screening even more accessible. In March, 20 Geneva’s drug stores partner with Novigenix for the fight against colorectal cancer by promoting different non-invasive screening solutions including the molecular blood test Colox and  fecal

Load More Posts

Web news

Find relevant information about colorectal cancer

Know the symptoms, but don’t wait to get screened

Colorectal cancer progresses slowly and doesn’t show signs or symptoms until an advanced stage1. Thus,  people who get cancer are diagnosed late whereas an early detection increases the chances of survival. Even if we don't have to wait for the first symptoms to get screened, it is important to recognize the signs that may be associated to colorectal cancer. In the article from Colorectal Cancer

Can Colorectal Cancer Be Prevented?

  Even if there is no sure way to prevent colorectal cancer, there are things you can do that might help lower your risk. Screening is one of those factors you can control and which help you to reduce the risk to develop a colorectal cancer.  The earlier a colorectal cancer is detected, the easier it is treated. Screening is very

Colorectal cancer screening should be self-evident

PREVENTION : Colorectal cancer screening is voluntary but the physicians strongly recommend it   Prof. Dr. med. Christoph Beglinger  - Specialist of Gastroenterology   Colorectal Cancer - Screening : Now, there are three options for the prevention.   Switzerland lags behind regarding colorectal cancer screening, according to international comparison. Only 30% of men and women over the age of 50 get screened. In fact,

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Privacy Notice